Eastern Caribbean Health Outcomes Research Network (ECHORN)

Cancer Clinical Trial

— ECHORN  

Official title:

Eastern Caribbean Health Outcomes Research Network (ECHORN)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01994811
• Other study ID #: 1108008959
• Secondary ID: 5U24MD006938
• Status: Completed
• Start date: April 2013
• Est. completion date: June 14, 2018

Study information

• Verified date: July 2022
• Source: Yale University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The Eastern Caribbean Health Outcomes Research Network (ECHORN) is a collaborative research study that examines the lifestyles, eating habits, and health behaviors associated with cancer, diabetes and heart disease in adult men and women living in the Eastern Caribbean.

Description:

The Eastern Caribbean Health Outcomes Research Network (ECHORN) has two aims: (1) To form a research collaborative across the Eastern Caribbean islands of Puerto Rico, the U.S. Virgin Islands, Barbados, and Trinidad & Tobago to recruit and follow a community-dwelling adult cohort to estimate the prevalence of known and potential risk factors associated with the development of heart disease, cancer, and diabetes and (2) To enhance health outcomes research leadership capacity in the region through a series of dedicated activities locally and abroad. ECHORN will expand clinical research with racial/ethnic minority populations in a transitioning part of the globe now threatened with an epidemic of noncommunicable chronic diseases (NCD). ECHORN's findings will have direct implications for the health disparities research and policy agenda in the mainland United States. In the long term, the links ECHORN will facilitate with local health policy delegations and global strategic organizational partners will promote the translation of research to improve health outcomes across the region. The collection and storage of biological specimens will also contribute to national biomonitoring projects and has the potential to identify unique risk and protective factors in the development of NCD.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2961
• Est. completion date: June 14, 2018
• Est. primary completion date: June 14, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Greater than or equal to 40 years of age

• English or Spanish language speaking

• Resident of island at least 10 years

• Able to provide informed consent

• Non-institutionalized at the time of data collection

• Stable contact/residential information

• No plans to relocate from island within the next 5 years

Related Conditions & MeSH terms

• Cancer
• Cardiovascular Disease
• Cardiovascular Diseases
• Diabetes

Locations

Country	Name	City	State
Barbados	University of the West Indies, Cave Hill Campus	Bridgetown
Puerto Rico	University of Puerto Rico Medical Sciences Campus	San Juan
Trinidad and Tobago	University of the West Indies, St. Augustine Campus	St. Augustine	West Indies
Virgin Islands (U.S.)	University of the Virgin Islands	Charlotte Amalie

Sponsors (2)

Lead Sponsor	Collaborator
Yale University	National Institute on Minority Health and Health Disparities (NIMHD)

Countries where clinical trial is conducted

Barbados,  Puerto Rico,  Trinidad and Tobago,  Virgin Islands (U.S.), 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of non-communicable diseases	Prevalence of non-communicable diseases, including cancer, heart disease and diabetes.	5 years